The Haemophilus influenzae type B IgG Antibody Test measures IgG levels against Hib bacteria to evaluate immune protection. Adequate antibody levels reflect vaccine response or past exposure, while low levels may indicate susceptibility to infection. This test supports assessment of immune status in children, immunocompromised patients, or individuals at risk for invasive Hib disease such as meningitis or pneumonia.

The Syphilis (RPR + FTA-ABS) panel is a diagnostic tool used to detect and confirm the presence of syphilis, a sexually transmitted infection (STI) caused by the bacterium Treponema pallidum. This panel combines two tests: the RPR (Rapid Plasma Reagin) Screen with Reflex to Titer, and the FTA-ABS (Fluorescent Treponemal Antibody Absorption) test, offering both initial screening and confirmatory diagnosis capabilities.

The Toxoplasma IgG Antibody Test detects IgG antibodies to Toxoplasma gondii, the parasite that causes toxoplasmosis. A positive result indicates past infection or immunity, while rising levels may suggest recent exposure. Doctors use this blood test to evaluate immune status in pregnant women, immunocompromised patients, or those at risk for complications. Results help guide diagnosis, monitor infection history, and inform patient care planning.

The Cytomegalovirus (CMV) IgG Antibody Test detects IgG antibodies to CMV, indicating past infection or immunity. This blood test helps determine prior exposure, assess immune status in pregnancy, transplant patients, or immunocompromised individuals, and guide risk evaluation. A positive result shows past CMV infection, while results are used with IgM testing to distinguish recent vs. past infection.

The Mumps Virus Titer Test measures IgG antibodies to determine immunity from prior infection or vaccination. A positive result indicates protective immunity, while a negative result suggests susceptibility to mumps. Doctors use this blood test to confirm immune status, check vaccine response, or meet school, travel, or employment requirements. It provides valuable information for individual protection and public health safety.

The Coxsackie B Virus Antibodies test is a diagnostic blood test used to detect antibodies produced by the immune system in response to a Coxsackie B virus infection. Coxsackie B viruses belong to the enterovirus family and are associated with a range of illnesses, from mild flu-like symptoms to more severe conditions such as viral myocarditis and meningitis. This test measures the presence of specific antibodies against Coxsackie B viruses, helping to confirm recent or past infections and assess the immune response to the virus. The test is particularly useful in identifying cases where Coxsackie B virus may be the underlying cause of unexplained cardiac, neurological, or systemic symptoms.

The Herpes Simplex Virus 2 (HSV-2) IgG HerpeSelect® Test with Reflex to HSV-2 Inhibition detects IgG antibodies specific to HSV-2, the virus causing genital herpes. The reflex inhibition assay confirms positive results, improving accuracy and reducing false positives. Doctors order this test to diagnose genital herpes, even in asymptomatic patients. Results help confirm infection status, guide counseling, and support treatment or management of HSV-2 and related complications.

 The Immunity Panel is a set of laboratory tests designed to assess an individual's immunity status against specific infectious diseases. By measuring the presence and levels of specific antibodies in the blood, the panel provides valuable insights into whether an individual has been previously exposed to these pathogens or has been vaccinated against them, thus offering protection.

The Pregnancy Blood Test is a qualitative test that detects human chorionic gonadotropin (hCG) in blood and reports results as Positive or Negative. A positive result confirms pregnancy, while a negative means no hCG detected. More sensitive than urine tests, it can confirm pregnancy in early stages. Doctors use this test to verify pregnancy, evaluate symptoms, or provide reliable confirmation for women seeking accurate reproductive health answers.

The Student Titers Panel evaluates immunity to key infections often required for school or healthcare enrollment. It includes Hepatitis B Surface Antibody, Measles IgG, Mumps IgG, Rubella IgG, Varicella-Zoster Virus IgG, and QuantiFERON-TB Gold Plus for tuberculosis. Results confirm vaccination response or past exposure, helping students meet program requirements and ensure protection against preventable diseases.

The Flunitrazepam and Metabolites Quantitative Urine Test measures flunitrazepam, a benzodiazepine, and its metabolites to evaluate drug exposure and metabolism. This test is often used in forensic, clinical, or compliance settings to confirm recent ingestion and monitor misuse. By quantifying parent drug and metabolites, it provides reliable evidence of exposure and supports assessment of benzodiazepine-related effects.

The Cytomegalovirus (CMV) IgG IgM Antibodies Test detects both recent and past infection with CMV, a common herpesvirus. IgM indicates recent or active infection, while IgG shows past exposure and possible immunity. Doctors order this test for pregnant women, immunocompromised patients, or those with unexplained fever or fatigue. Results help diagnose CMV, guide treatment, and assess risk of complications such as congenital infection or organ damage.

The Coccidioides Antibody Complement Fixation and Immunodiffusion Test measures antibody response to fungal infection caused by Coccidioides species. It helps distinguish active from past infection, evaluate immune activity, and monitor disease progression. This test provides valuable information for assessing Valley Fever, systemic fungal disease, and complications involving the lungs, skin, or other organs.

The Cytomegalovirus (CMV) IgM Antibody Test detects IgM antibodies, indicating a recent or active CMV infection. This blood test helps diagnose primary CMV, reactivation, or reinfection, especially important for pregnant women, transplant candidates, and immunocompromised patients. Used with CMV IgG testing, it helps distinguish new infections from past exposure for accurate clinical evaluation.

The Ehrlichia chaffeensis IgG IgM Antibodies Test detects immune response to the bacterium responsible for human monocytic ehrlichiosis (HME). Measuring both IgM and IgG provides information on recent or past infection, helping identify acute illness or prior exposure. This blood test supports evaluation of tick-borne disease in patients with symptoms such as fever, fatigue, or cytopenias, guiding clinical assessment and patient management.

The Herpes 1 IgG Antibody Test detects IgG antibodies to HSV-1, the virus that commonly causes oral herpes (cold sores). IgG develops weeks after exposure and remains for life, making this test useful for confirming past infection and exposure history. Doctors order it for patients with oral sores, blisters, or concerns about herpes transmission. Results help confirm HSV-1 infection, guide treatment, and support counseling and prevention strategies.

The Pregnancy Urine Test detects human chorionic gonadotropin (hCG), a hormone produced shortly after implantation, to confirm pregnancy. It provides quick, reliable results from a urine sample and is often used to verify early pregnancy when a menstrual period is missed. Doctors may order this test to confirm results before beginning prenatal care. It is a simple, accurate, and widely used screening tool for pregnancy detection.